Oncology PracticeLung Cancer Expert at ASCO: From Fatal to ‘Chronic Disease’June 20, 2024ASCO Lung Cancer
Oncology PracticeASCO Releases Vaccination Guidelines for Adults With CancerMarch 28, 2024Preventive CareImmuno-oncologyLung CancerMelanomaASCO Breast CancerASCO Lung CancerMultiple Myeloma
Oncology PracticeMy picks for best of ASCO 2022June 28, 2022ASCO Lung CancerASCO Breast CancerBreast CancerGenitourinary CancerGynecologic CancerLung CancerMetastatic Breast Cancer
Oncology PracticePatients with blood cancers underutilize palliative careJune 23, 2022Patient & Survivor CareASCO Lung CancerLeukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersPractice Management
Oncology PracticePromising treatment option for incurable lung cancer described as ‘significant’June 13, 2022Lung CancerASCO Lung Cancer
Oncology PracticeOncologists flock to Chicago for ASCO, after 2 years onlineJune 3, 2022ASCO Breast CancerASCO Lung Cancer
Key Presentations on Advanced Non–Small Cell Lung Cancer From ASCO 2021June 28, 2021ASCO Lung CancerLung Cancer
Oncology PracticeHER3-targeted treatment demonstrates efficacy and safety in phase 1 lung cancer studyJune 11, 2021Lung CancerASCO Lung Cancer
Oncology PracticeSurgical outcomes favor addition of nivolumab to neoadjuvant chemo in resectable lung cancersJune 10, 2021Lung CancerASCO Lung Cancer
Oncology PracticeNasal swab test helps identify malignant lung nodulesJune 10, 2021Lung CancerASCO Lung Cancer
Oncology PracticeUrine metabolites could predict end of life in lung cancerJune 10, 2021Lung CancerASCO Lung Cancer
Oncology PracticeVinorelbine survival benefit in mesothelioma overshadowed by advances in immuno-oncologyJune 10, 2021Lung CancerASCO Lung Cancer
Oncology PracticeKRAS inhibitor improved survival in phase 2 lung cancer trialJune 6, 2021Lung CancerASCO Lung Cancer
